PeptidePedia The community reference

Contributions of GMP_Gita

User contributions·33 logged edits·page 1 of 1

Contributions by GMP_Gita, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 10,188 edits includes activity predating the current log.

  1. 12:44, 18 Jul 2026 (diff | hist) Regulatory status by jurisdiction 4,444 ±0 split the compounding position from the manufacturing position
  2. 15:49, 19 Jun 2026 (diff | hist) Body composition assessment 5,029 ±0 ce per PP:MOS
  3. 11:05, 16 Jun 2026 (diff | hist) Talk:Solid-phase peptide synthesis 674 +183 /* Process detail versus quality attributes */ new section
  4. 09:40, 2 Jun 2026 (diff | hist) Talk:Active pharmaceutical ingredient 537 +138 /* Same line as pharmaceutical material */ new section
  5. 13:50, 24 May 2026 (diff | hist) Talk:ISO 9001 748 +101 /* Accredited versus unaccredited bodies */ reply
  6. 02:52, 5 May 2026 (diff | hist) Temperature excursion 24,964 ±0 m add the customs-detention point as a logistics fact, sourced
  7. 16:42, 5 Apr 2026 (diff | hist) Trifluoroacetate counterion 5,116 ±0 state the column chemistry and the gradient the figure was obtained on
  8. 09:45, 19 Feb 2026 (diff | hist) Talk:ISO 9001 400 +151 /* Scope is on the certificate */ new section
  9. 21:10, 14 Feb 2026 (diff | hist) Customs seizure 4,785 ±0 m split the compounding position from the manufacturing position
  10. 09:55, 4 Feb 2026 (diff | hist) Talk:Good manufacturing practice 400 +167 /* Regulators do not issue perpetual certificates */ new section
  11. 13:20, 3 Feb 2026 (diff | hist) Talk:Lot traceability 611 +142 /* A lot is a procedural object */ reply
  12. 13:20, 22 Jan 2026 (diff | hist) Talk:Contract development and manufacturing organisation 611 +92 /* Not inherently suspicious */ reply
  13. 04:34, 3 Dec 2025 (diff | hist) USP General Chapter 71 4,657 ±0 sentence case in headings per PP:MOS
  14. 10:27, 1 Dec 2025 (diff | hist) Regulatory status by jurisdiction 4,444 ±0 clarify the difference between a marketing authorisation and a registration
  15. 15:40, 30 Nov 2025 (diff | hist) Hunan Aslsen Technology 15,272 ±0 fix a dangling clause
  16. 00:25, 1 Nov 2025 (diff | hist) AmbioPharm 6,078 +1,561 rm a duplicated category
  17. 09:08, 14 Aug 2025 (diff | hist) Talk:Research use only 1,096 +197 /* Do we state the position for any named jurisdiction? */ reply
  18. 01:48, 10 Jul 2025 (diff | hist) Regulatory status by jurisdiction 4,262 +32 m rm the claim that the position has changed; no source supports it
  19. 09:33, 15 May 2025 (diff | hist) Talk:Beyond-use date 1,096 +176 /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  20. 07:28, 20 Apr 2025 (diff | hist) Good manufacturing practice 3,919 ±0 add the good-manufacturing-practice framework by name
  21. 09:01, 18 Apr 2025 (diff | hist) HOMA-IR 3,431 ±0 rm the claim that the marker predicts outcome; the cited study is cross-sectional
  22. 05:09, 18 Apr 2025 (diff | hist) Missed dose 4,407 ±0 serial comma per PP:MOS
  23. 17:57, 28 Jan 2025 (diff | hist) Triple agonist 3,147 +27 convert the substitution list to a table so the analogues line up
  24. 19:25, 7 Jan 2025 (diff | hist) Personal importation policy 2,232 +42 add the pharmacopoeial chapter reference
  25. 15:27, 28 Dec 2024 (diff | hist) GL Biochem (Shanghai) 9,469 +920 add the note that self-published material is usable only for what it states about itself
  26. 08:37, 15 Dec 2024 (diff | hist) Good manufacturing practice 2,501 ±0 m attribute the enforcement statement to the published policy
  27. 09:00, 12 Dec 2024 (diff | hist) Patent expiry and biosimilars 1,327 +1,327 N new article: drug regulation, expansion welcome
  28. 03:29, 18 Nov 2024 (diff | hist) Injection site rotation 2,929 ±0 m add the preservative point: unpreserved diluent changes the interval
  29. 03:11, 14 Sep 2024 (diff | hist) Good manufacturing practice 1,773 ±0 m add the effective date to the regulatory table
  30. 18:08, 19 Aug 2024 (diff | hist) Retatrutide 3,206 +484 add CAS number, sourced
  31. 22:22, 18 Aug 2024 (diff | hist) Proglucagon 2,661 +423 attribute the gastric-emptying effect to the study that measured it
  32. 11:10, 13 Aug 2024 (diff | hist) Research use only 2,879 +1,223 British spelling per PP:MOS
  33. 05:40, 2 Aug 2024 (diff | hist) Research use only 1,656 +1,656 N create article — regulatory stub